Marker and its use of acute coronary syndrome

摘要

The present invention provides a method of testing plasma and/or serum of a test subject for determining the pathology or onset risk of acute coronary syndrome, including (1) a step of measuring a soluble amyloid ² precursor protein (sAPP) 770 level of plasma and/or serum of a test subject; and (2) a step of relating the plasma and/or serum sAPP770 level(s) measured in (1) to the pathology or onset risk of acute coronary syndrome.